Edgewell Personal Care (EPC)
NYSEConsumer StaplesHousehold & Personal ProductsSnapshot 2026-09-04
NYSEConsumer StaplesHousehold & Personal ProductsSnapshot 2026-09-04
QuarterlyIQ Insights · EPC
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 9 valuation methods, at three horizons. As of 2026-09-04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $29 EPC trades at 16× p/e, below its 17× p/e peer median. Our $31 fair value sits above the price. It's a high-confidence read. Analysts target $23–$34. Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| analyst target | 12M | $29.00 | — | — | Analyst | high |
| graham number | 12M | $36.01 | — | — | TTM | high |
| Peer EV/EBITDA | 12M | $31.68 | 11.7 | 4.33 | TTM | high |
| Peer P/FCF | 12M | $17.89 | 15.9 | 1.12 | TTM | high |
| Peer P/E |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
A long-thesis check that carries the widest uncertainty of the three horizons.
Around the middle on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
$23.00 – $34.00 (median $29.00) · 7 analysts · as of 2026-08-07
No fragility gates fired. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
At today's price you pay about 23% over what the business is worth with no growth; closing that gap needs roughly — years of the forecast growth to come through. These describe the expectations embedded in the price, not a forecast of the move. Reverse-DCF base: $2.41/sh owner earnings.
Roughly priced in line with peers.
Self-history needs ~20 months of data.
Trailing four: 2025-Q3, 2026-Q1, 2026-Q2, 2026-Q3
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
| 12M |
| $31.70 |
| 15.8 |
| 2.01 |
| ntm analyst |
| high |
| Peer P/S | 12M | $41.10 | 0.9 | 48.15 | TTM | high |
| PEG | 12M | $36.06 | 19.6 | 1.84 | TTM | high |
| residual income | 12M | $26.73 | — | — | TTM | high |
| triangulated | 12M | $32.42 | 16.8 | 1.93 | Triangulated | high |
| Peer P/FCF | 3Y | $6.34 | 15.9 | 0.40 | Hist. CAGR(prov.) | medium |
| Peer P/E | 3Y | $44.12 | 15.8 | 2.79 | Analyst | medium |
| Peer P/S | 3Y | $30.73 | 0.9 | 36.01 | Analyst | medium |
| PEG | 3Y | $54.73 | 19.6 | 2.79 | Analyst | medium |
| Peer P/FCF | 5Y | $3.18 | 15.9 | 0.20 | Hist. CAGR(prov.) | medium |
| Peer P/E | 5Y | $36.35 | 15.8 | 2.30 | Analyst | medium |
| Peer P/S | 5Y | $25.32 | 0.9 | 29.67 | Analyst | medium |
| PEG | 5Y | $45.09 | 19.6 | 2.30 | Analyst | medium |